Table 2 Covid-19 vaccination strategies
From: Covid-19 vaccination: a mixed methods analysis of health system resilience in Latin America
Country | ICS ratio | Accessibility | Supply scheme | |
|---|---|---|---|---|
Early performers | Chile | 0.29 | HIGH | • Early agreements and negotiations • COVAX: +7 million doses |
• Massive vaccination centers | ||||
Uruguay | 0.33 | HIGH | • Late negotiations • COVAX: 1.5 million doses | |
• Massive vaccination centers | ||||
Prompt performers | Colombia | 0.42 | MEDIUM | • Anticipated negotiations • COVAX: 20 million doses |
• Late opening of massive vaccination centers • Customized vaccination campaigns depending on the population characteristics | ||||
Ecuador | 0.39 | MEDIUM | • COVAX doses: + 3 million doses | |
• Massive vaccination centers | ||||
Delayed performers | Dominican Republic | 0.38 | HIGH | • COVAX doses: +2 million doses |
• Intramural and Extramural vaccination centers | ||||
Paraguay | 0.38 | MEDIUM | • Early negotiation with five pharmaceuticals • COVAX doses: +4 million doses | |
• Drive-through and pedestrian vaccination centers • Differentiated locations between weekdays and weekends | ||||
Jamaica | 0.44 | HIGH | • COVAX doses: 124,800 • First country receiving COVAX doses in the Caribbean | |
• Mobile and permanent vaccination centers |